News|Articles|December 6, 2024
The Future of Cell Therapies
Author(s)Charles River
When complexities of developing donor-derived cell therapies are considered, NGS emerges clearly as a better, cost-effective yet regulatory-compliant solution.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Industry Experts Probe CNPV Impacts: Part II
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control
5
